Screener
Amneal Pharmaceuticals, Inc. AMRX Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Amneal Pharmaceuticals, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Amneal Pharmaceuticals, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 5:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001723128-26-000031
FAQ
- What is Amneal Pharmaceuticals, Inc.'s current ratio?
- Amneal Pharmaceuticals, Inc. (AMRX) reported current ratio of 2.2× in Q2 2026.
- How has Amneal Pharmaceuticals, Inc.'s current ratio changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s current ratio increased by 54.0% year-over-year, from 1.4× to 2.2×.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s current ratio?
- Over 5 years (2020 to 2025), Amneal Pharmaceuticals, Inc.'s current ratio has grown at a -1.1% compound annual growth rate (CAGR), from 2.3× to 2.2×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Amneal Pharmaceuticals, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude